Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Arrowhead Pharmaceuticals Inc., 3 years.
Arrowhead Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 17, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −547 | $22.04 | $12,056 |
| Dec 16, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −5,000 | $21.90 | $109,500 |
| Jan 11, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −1,811 | $37.76 | $68,383 |
| Jan 11, 2024 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −1,100 | $38.55 | $42,405 |
| Dec 15, 2023 | Arrowhead Pharmaceuticals Inc. | Grant or award | +14,987 | $25.41 | $380,820 |
| May 5, 2023 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −6,500 | $40.90 | $265,850 |
| Feb 27, 2023 | Arrowhead Pharmaceuticals Inc. | Open-market sale | −875 | $32.62 | $28,543 |
| Jan 10, 2023 | Arrowhead Pharmaceuticals Inc. | Grant or award | +7,867 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.